Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The Publications section now notes that PubMed publications are automatically populated and may not be about the study. The revision label changed from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T10:40:10.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Notice about government funding and NIH operating status was removed from the page's deletions section, with no changes to the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T06:56:31.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The new screenshot shows only minor user-interface adjustments, such as spacing and header alignment, with no changes to core trial information. There are no edits to the study title, conditions, interventions, eligibility criteria, enrollment, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:58:24.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    2%
    Check dated 2025-10-06T05:25:16.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:03:56.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content, pricing, stock availability, or time-slot availability.
    Difference
    0.1%
    Check dated 2025-09-14T19:12:26.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.